Palmer, Ewelina
Johar, Ichha
Little, Dustin J.
Karlsson, Niklas
Funding for this research was provided by:
AstraZeneca
Article History
Received: 7 December 2023
Accepted: 21 March 2024
First Online: 9 May 2024
Declarations
:
: Ewelina Palmer, Dustin J. Little and Niklas Karlsson are employees of AstraZeneca and hold shares in AstraZeneca. Ichha Johar is an employee of IQVIA, which received funds from AstraZeneca to collect and analyse the study data.
: Ethics approval was obtained from the WIRB–Copernicus Group Institutional Review Board in May 2021 (study no. 1304203) for the qualitative interview research protocol, interview guide and all patient communication documents. The interviews were conducted in accordance with the recommended guidelines provided by the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices Task Force and reflect the US Food and Drug Administration guidance on methods to identify what is important to patients. All participants provided informed consent online. Written informed consent for the publication of the patients’ clinical details was obtained.